Since its 2015 IPO, KDA has maintained sustained
and measured growth. We maximize returns for our
shareholders without limiting the development potential of our
solutions and their marketing.
Determinedly in development and growth mode, KDA is stepping up its marketing efforts for its solutions (e-prescription and e-adherence) in order to capitalize on business opportunities in Quebec, Canada and internationally.
Access our historical financial statements and relevant press releases on SEDAR